AMPLIFICATION PATENT RIGHTS definition

AMPLIFICATION PATENT RIGHTS means the nucleic acid amplification processes, including particularly the PCR process, covered by: United States Patents Nos. 4,683,195, 4,683,202 and 4,965,188; and any corresponding amplification process claim in patents and patent applications in other countries claiming priority of any of them. Amplification Patent Rights include rights only under the identified Roche patents and applications. They do not include rights, expressly or by implication, under any other Roche or PE CORP patent or application, or to any claim to reagents, apparatus, or a system of reagents and apparatus.
Sample 1Sample 2Sample 3
AMPLIFICATION PATENT RIGHTS means the nucleic acid amplification processes, including particularly the PCR process, covered by: United States Patent Nos. 4,683,195, 4,683,202 and 4,695,188; any amplification process claim issuing from an application claiming priority of U.S. application Serial No. 833,368 or U.S. application Serial No. 899,061 (both filed in 1986); and any corresponding amplification process claim in patents and patent applications in other countries claiming priority of any of them.
Sample 1Sample 2Sample 3
AMPLIFICATION PATENT RIGHTS means the nucleic acid amplification processes covered by United States Patent Nos. 4,683,195, 4,683,202 and 4,965,188, and those claims in foreign patents and patent applications which correspond to issued claims in the above patents and which foreign patents and patent applications claim priority from patent applications on which the above patents are based, and access to which patents and patent applications are necessary for INVITROGEN to manufacture, use and sell products which include a label license under AMPLIFICATION PATENT RIGHTS, in accordance with the rights granted in Sections 2.2 - 2.3 hereto.
Sample 1Sample 2

Examples of AMPLIFICATION PATENT RIGHTS in a sentence

  • If SCS elects to terminate this Agreement pursuant to this section, it shall within thirty (30) days of said termination, notify each of its customers that SCS is no longer licensed under AMPLIFICATION PATENT RIGHTS, TAQ PATENT RIGHTS, or SEQUENCING PATENT RIGHTS.

  • This Agreement and its effect are subject to and shall be construed and enforced in accordance with the law of the State of New Jersey, U.S.A., except as to any issue which by the law of New Jersey depends upon the validity, scope or enforceability of any patent within AMPLIFICATION PATENT RIGHTS, TAQ PATENT RIGHTS, or SEQUENCING PATENT RIGHTS which issue shall be determined in accordance with the applicable patent laws of the United States or the relevant foreign jurisdiction.

  • FIELD TO CONVEY A LABEL LICENSE AND TO PROMOTE FOR USE IN PCR A license under the AMPLIFICATION PATENT RIGHTS for automated performance of the PCR PROCESS in the RESEARCH FIELD has an up-front fee component based on the capacity of thermal cyclers used, and a running-royalty component for each use of the process.

  • AND TO PROMOTE FOR PCR A license under the AMPLIFICATION PATENT RIGHTS for automated performance of the PCR PROCESS in all or some of the APPLICATION FIELDS includes an up-front fee component as described in Section 2.2 and a running royalty component.

  • It is specifically understood that as between the Parties to this Agreement, ROCHE reserves the right itself or through its AFFILIATES to practice under POLYMERASE PATENT RIGHTS, SEQUENCING PATENT RIGHTS, RT and RT-PCR PATENT RIGHTS and AMPLIFICATION PATENT RIGHTS, including the PCR PROCESS itself, and to sublicense, assign or otherwise transfer such rights to others for any purpose whatsoever.

  • A license under the AMPLIFICATION PATENT RIGHTS for automated performance of the PCR PROCESS in the RESEARCH FIELD has an up-front fee component based on the capacity of thermal cyclers used, and a running-royalty component for each use of the process.

  • If CLI elects to terminate this Agreement pursuant to this section, it shall within thirty (30) days of said notice to ROCHE, also notify each of its customers that CLI is no longer licensed under AMPLIFICATION PATENT RIGHTS, POLYMERASE PATENT RIGHTS, SEQUENCING PATENT RIGHTS or RT and RT-PCR PATENT RIGHTS.

  • Also, for purposes of this particular paragraph, "Actively Promoted" shall mean advertised or technically supported for use in AMPLIFICATION PATENT RIGHTS.

  • This license is granted to CLI as of October 1, 1996 and will expire on the expiration of the last to expire of the patents within AMPLIFICATION PATENT RIGHTS, SEQUENCING PATENT RIGHTS, POLYMERASE PATENT RIGHTS, RT and RT-PCR PATENT RIGHTS to the extent a license of rights under any of the foregoing surviving Patent Rights is being exercised pursuant to Sections 2.2-2.6 hereto.

  • No rights are granted expressly, by implication or by estoppel under AMPLIFICATION PATENT RIGHTS, SEQUENCING PATENT RIGHTS, RT- and RT-PCR PATENT RIGHTS or any other ROCHE patent rights by the grant of this Section.


More Definitions of AMPLIFICATION PATENT RIGHTS

AMPLIFICATION PATENT RIGHTS means the nucleic acid amplification processes, including particularly the PCR process, covered by Valid Claims of United States Patents Nos. 4,683,195, 4,683,202 and 4,965,188; and any corresponding amplification process Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act. Valid Claim in patents and patent applications in other countries claiming priority of any of them. Amplification Patent Rights include rights only under the foregoing identified Roche patents and applications. They do not include rights, expressly or by implication, under any other Roche or ABI patent or application, or to any claim to reagents, apparatus, or a system of reagents and apparatus.
Sample 1Sample 2
AMPLIFICATION PATENT RIGHTS means the nucleic acid amplification processes, including particularly the PCR process, covered by: United States Patents Nos. 4,683,195, 4,683,202 and 4,965,188; and any corresponding amplification process Valid Claim in patents and patent applications in other countries claiming priority of any of them.
Sample 1
AMPLIFICATION PATENT RIGHTS means the nucleic acid amplification processes covered by United States Patent Nos. 4,683,195, 4,683,202 and 4,965,188, and those claims in foreign patents and patent applications which correspond to issued claims in the above patents and which foreign patents and patent applications claim priority from patent applications on which the above patents are based, and access to which patents and patent applications are necessary for CLI to manufacture, use and sell products which include a label license under AMPLIFICATION PATENT RIGHTS, in accordance with the rights granted in Sections 2.3 - 2.4 hereto.
Sample 1

Related to AMPLIFICATION PATENT RIGHTS

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Program Patent Rights means any Patent Rights that are Controlled by one or both parties and that Cover any Program Technology or Program Materials. For clarification, such Program Patent Rights include the entire scope of all of the claims contained in such Patent Rights.

  • Patent Rights means all patents and patent applications, including all divisionals, continuations, substitutions, continuations-in-part, re-examinations, reissues, additions, renewals, extensions, registrations, and supplemental protection certificates and the like of any of the foregoing.

  • Collaboration Patents means any and all Patents that claim or cover any of the Collaboration Know-How.

  • Licensed Patent Rights means:

  • Joint Patent Rights means all Patent Rights claiming a Joint Invention.

  • Licensee Patents means all patent applications and patents Controlled by Licensee that claim (a) [***], or (b) [***].

  • Product Patents means any Patent Controlled or owned by Quoin in the Territory that, absent the license in Section 2.1, would be infringed by the importation, sale, or use of the Product in the Territory by a third party.

  • Licensed Patents means (a) all United States patents and patent applications listed in Exhibit A, as modified pursuant to Section 2.6.1, including patents arising from such patent applications; and (b) any re-examination certificates thereof, and their foreign counterparts and extensions, continuations, divisionals, and re-issue applications; provided that “Licensed Patents” will not include any claim of a patent or patent application covering any Manufacturing Technology.

  • Patent Right means: (a) an issued or granted patent, including any extension, supplemental protection certificate, registration, confirmation, reissue, reexamination, extension or renewal thereof; (b) a pending patent application, including any continuation, divisional, continuation-in-part, substitute or provisional application thereof; and (c) all counterparts or foreign equivalents of any of the foregoing issued by or filed in any country or other jurisdiction.

  • Joint Patents means all Patents claiming any Joint Invention.

  • Assigned Patent Rights means all of the following, whether now owned or hereafter acquired or arising:

  • Company Patents means Patents owned by the Company or used or held for use by the Company in the Business.

  • Licensed Patent means Stanford's rights in U.S. Patent Application, Serial Number , filed , any foreign patent application corresponding thereto, and any divisional, continuation, or reexamination application, extension, and each patent that issues or reissues from any of these patent applications. Any claim of an unexpired Licensed Patent is presumed to be valid unless it has been held to be invalid by a final judgment of a court of competent jurisdiction from which no appeal can be or is taken. “Licensed Patent” excludes any continuation-in-part (CIP) patent application or patent.

  • Licensed IP means the Licensed Patents and the Licensed Know-How.

  • Regents' Patent Rights means The Regents interest in the claims of the United States patents and patent applications, corresponding foreign patents and patent applications (requested under Paragraph 7.3 herein), and any reissues, extensions, substitutions, continuations, divisions, and continuation-in-part applications (but only those claims in the continuation-in-part applications that are entirely supported in the specification and entitled to the priority date of the parent application) based on the patent applications listed in Appendix A (UC Case Nos [ * ] and [ * ]).

  • Joint Patent means a patent that issues from a Joint Patent Application.

  • Program Technology means Program Know-How and Program Patents.

  • Licensee Technology means the Licensee Know-How and Licensee Patents.

  • Valid Patent Claim means a claim of an issued and unexpired Patent which has not been disclaimed, revoked, held unenforceable or invalid by a decision of a court or other governmental agency of competent jurisdiction, unappealable or unappealed within the time allowed for appeal, and which has not been admitted to be invalid or unenforceable through reissue or disclaimer or otherwise.

  • Licensed Technology means the Licensed Patents and the Licensed Know-How.

  • Collaboration IP means Collaboration Know-How and Collaboration Patents.

  • Licensed IP Rights means, collectively, the Licensed Patent Rights and the Licensed Know-How Rights.

  • Third Party Technology means all Intellectual Property and products owned by third parties and licensed pursuant to Third Party Licenses.

  • Patent Applications means all published and unpublished nonprovisional and provisional patent applications, reexamination proceedings, invention disclosures and records of invention, applications for certificates of invention and priority rights, in any country and regardless of formal name, including without limitation, substitutions, continuations, continuations-in-part, divisions, renewals, revivals, reissues, re-examinations and extensions thereof.

  • Joint IP means Joint Know-How and Joint Patents.